Inhibition of PTTG1 suppresses proliferation and promotes differentiation of neuroblastoma cells by inducing autophagy. [PDF]
Yuan L, Wang X, Dai K, Wong KKY.
europepmc +1 more source
The current and future landscape of RNA-based therapies and diagnostics. [PDF]
Freije CA, Arechavala-Gomeza V.
europepmc +1 more source
C16-siRNAs in Focus: Development of ALN-APP, a Promising RNAi-Based Therapeutic for Alzheimer's Disease. [PDF]
Titze-de-Almeida R +3 more
europepmc +1 more source
Correction: Circ-IGF1R plays a significant role in psoriasis via regulation of a miR-194-5p/CDK1 axis. [PDF]
Fang Y +5 more
europepmc +1 more source
Non-coding RNAs in laryngeal squamous cell carcinoma: diagnostic biomarkers and emerging exosome-based therapeutic strategies. [PDF]
Elgormus MN, Biltekin B, Ibas M.
europepmc +1 more source
Related searches:
Small interfering RNA (siRNA)-based therapeutics
Drug and Therapeutics Bulletin, 2023In early studies in simple organisms and mammalian cell lines, small interfering RNA (siRNA) molecules were found to allow experimental cleavage of intracellular messenger RNA (mRNA; the transcription product of a cell gene), reducing the levels of the proteins that would otherwise be formed by the action of the mRNA, thereby ‘silencing’ a specific ...
openaire +2 more sources
RNA Interference and Small Interfering RNAs
ChemBioChem, 2001The term aRNA interferenceo (RNAi) was coined after the groundbreaking discovery that injection of double-stranded RNA (dsRNA) into the nematode Caenorhabditis elegans leads to specific silencing of genes highly homologous in sequence to the delivered dsRNA.
openaire +3 more sources
Chemical Modification of Small Interfering RNA
2011Chemically synthesized siRNAs are widely used for gene silencing. For in vitro applications, stability, delivery, and immunological issues are rarely problematic, but for in vivo applications the situation is different. Limited stability, undesirable pharmacokinetic behaviour, and unanticipated side effects from the immune system call for more careful ...
Bramsen, Jesper Bertram, Kjems, Jørgen
openaire +2 more sources
Small Interfering RNA for Effective Cancer Therapies
Mini-Reviews in Medicinal Chemistry, 2011Small interfering RNA (siRNA) has become a specific and powerful tool to turn off the expression of target genes, and has turned into a promising tool in molecular medicine. It can be targeted against cancer by several strategies. These include the suppression of overexpressed oncogenes, retarding cell division by interfering with cyclins and related ...
X, Wang, Y, Chen, J, Ren, X, Qu
openaire +2 more sources

